{"id":183618,"date":"2025-02-06T15:17:00","date_gmt":"2025-02-06T15:17:00","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/news-events\/data\/why-is-hims-stock-going-down\/"},"modified":"2025-02-06T15:17:00","modified_gmt":"2025-02-06T15:17:00","slug":"why-is-hims-stock-going-down","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/en\/knowledge-base\/markets\/why-is-hims-stock-going-down\/","title":{"rendered":"Why is Hims stock going down? Analysis, Influencing factors, Prospects"},"content":{"rendered":"
<\/div><\/div>","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":183619,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[21],"tags":[28,45],"class_list":["post-183618","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-markets","tag-investment","tag-stock"],"acf":{"h1":"Why is Hims stock going down?","h1_source":{"label":"H1","type":"text","formatted_value":"Why is Hims stock going down?"},"description":"Explore the reasons behind Hims & Hers Health Inc.'s stock performance. Uncover factors influencing \"why is HIMS stock going down\" today.","description_source":{"label":"Description","type":"textarea","formatted_value":"Explore the reasons behind Hims & Hers Health Inc.'s stock performance. Uncover factors influencing \"why is HIMS stock going down\" today."},"intro":"Wondering why Hims & Hers stock is going down today? Dive into the latest analysis and uncover the key reasons behind its recent decline, along with expert insights and trading opportunities on Pocket Option!","intro_source":{"label":"Intro","type":"text","formatted_value":"Wondering why Hims & Hers stock is going down today? Dive into the latest analysis and uncover the key reasons behind its recent decline, along with expert insights and trading opportunities on Pocket Option!"},"body_html":"
\r\n

Hims & Hers Health Inc. (NYSE: HIMS): An In-Depth Analysis of Recent Stock Performance<\/h2>\r\n<\/div>\r\n
\r\n

Hims & Hers Health Inc., a prominent telehealth company, has experienced significant fluctuations in its stock price recently. Understanding the underlying factors contributing to these movements is essential for investors and stakeholders.\u200b<\/p>\r\n\r\n<\/div>\r\n

\r\n

Recent Developments Impacting Hims & Hers Stock<\/p>\r\n\r\n<\/div>\r\n

\r\n
    \r\n \t
  1. FDA Decision on Semaglutide Shortage: In February 2025, the U.S. Food and Drug Administration (FDA) removed semaglutide injection products, including Novo Nordisk's Ozempic and Wegovy, from its shortage list. This change ended the supply constraints that had previously allowed companies like Hims & Hers to offer compounded versions of these medications. The FDA's action has raised concerns about Hims & Hers' ability to maintain its revenue streams from these products.<\/li>\r\n \t
  2. Expansion of Weight-Loss Offerings: In response to the FDA's decision, Hims & Hers announced plans to introduce Eli Lilly's weight-loss drug, Zepbound, and generic versions of Novo Nordisk's liraglutide. The company aims to diversify its weight-loss product portfolio to offset potential revenue losses from semaglutide. However, Zepbound's high monthly cost of $1,899 may limit its accessibility to a broader customer base.<\/li>\r\n \t
  3. Analysts' Perspectives:\r\n
      \r\n \t
    1. Michael Cherny, Analyst at Leerink Partners: Cherny views the expansion of Hims & Hers' weight-loss offerings positively but expresses concerns over the high pricing of Zepbound. He notes that while the strategy may broaden the customer base, the premium pricing could be a limiting factor. \u200b<\/li>\r\n \t
    2. Daniel Grosslight, Analyst at Citi: Grosslight questions the company's optimistic sales forecasts, suggesting that the anticipated rapid acceleration in sales may be overly ambitious given the current market dynamics.<\/li>\r\n<\/ol>\r\n<\/li>\r\n<\/ol>\r\n<\/div>\r\n
      \r\n

      Current Stock Performance<\/h2>\r\n<\/div>\r\n
      \r\n

      As of April 2, 2025, Hims & Hers Health Inc. (HIMS) is trading at $31.05 per share, reflecting a 5.14% increase from the previous close. This uptick may be attributed to the company's efforts to adapt to the changing regulatory environment and its strategic initiatives to expand product offerings.\u200b<\/p>\r\n\r\n<\/div>\r\n

      \r\n

      Trading Opportunities with Pocket Option<\/h2>\r\n<\/div>\r\n
      \r\n
      \"img\"<\/div>\r\n<\/div>\r\n
      \r\n

      For investors interested in capitalizing on the volatility of different assets, the Pocket Option platform offers unique trading opportunities:<\/p>\r\n\r\n<\/div>\r\n

      \r\n